% alzhub.org library filter
% Source: https://alzhub.org/research?score_min=67&journal=Nature+aging
% 9 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{shulman2023-38012285,
  author  = {Shulman, M. and Kong, J. and O'Gorman, J. and Ratti, E. and Rajagovindan, R. and Viollet, L. and Huang, E. and Sharma, S. and others},
  title   = {{TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease}},
  journal = {Nature aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00523-w},
  pmid    = {38012285},
  url     = {https://doi.org/10.1038/s43587-023-00523-w}
}

@article{ossenkoppele2025-40155777,
  author  = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others},
  title   = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}},
  journal = {Nature Aging},
  year    = {2025},
  doi     = {10.1038/s43587-025-00835-z},
  pmid    = {40155777},
  url     = {https://doi.org/10.1038/s43587-025-00835-z}
}

@article{fang2021-35572351,
  author  = {Fang, J. and Zhang, P. and Zhou, Y. and Chiang, C. W. and Tan, J. and Hou, Y. and Stauffer, S. and Li, L. and others},
  title   = {{Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease}},
  journal = {Nature aging},
  year    = {2021},
  doi     = {10.1038/s43587-021-00138-z},
  pmid    = {35572351},
  url     = {https://doi.org/10.1038/s43587-021-00138-z}
}

@article{brum2023-37653254,
  author  = {Brum, W. S. and Cullen, N. C. and Janelidze, S. and Ashton, N. J. and Zimmer, E. R. and Therriault, J. and Benedet, A. L. and Rahmouni, N. and Tissot, C. and Stevenson, J. and Servaes, S. and Triana-Baltzer, G. and others},
  title   = {{A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases}},
  journal = {Nature Aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00471-5},
  pmid    = {37653254},
  url     = {https://doi.org/10.1038/s43587-023-00471-5}
}

@article{therriault2024-39533113,
  author  = {Therriault, J. and Janelidze, S. and Benedet, A. L. and Ashton, N. J. and Arranz Martínez, J. and Gonzalez-Escalante, A. and Bellaver, B. and Alcolea, D. and others},
  title   = {{Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability}},
  journal = {Nature aging},
  year    = {2024},
  doi     = {10.1038/s43587-024-00731-y},
  pmid    = {39533113},
  url     = {https://doi.org/10.1038/s43587-024-00731-y}
}

@article{montoliugaya2025-40847200,
  author  = {Montoliu-Gaya, Laia and Salvadó, Gemma and Therriault, Joseph and Nilsson, Johanna and Janelidze, Shorena and Weiner, Sophia and Ashton, Nicholas J and Benedet, Andrea L and others},
  title   = {{Plasma tau biomarkers for biological staging of Alzheimer's disease}},
  journal = {Nature aging},
  year    = {2025},
  doi     = {10.1038/s43587-025-00951-w},
  pmid    = {40847200},
  url     = {https://doi.org/10.1038/s43587-025-00951-w}
}

@article{salvado2024-38514824,
  author  = {Salvadó, G. and Horie, K. and Barthélemy, N. R. and Vogel, J. W. and Pichet Binette, A. and Chen, C. D. and Aschenbrenner, A. J. and Gordon, B. A. and others},
  title   = {{Disease staging of Alzheimer's disease using a CSF-based biomarker model}},
  journal = {Nature aging},
  year    = {2024},
  doi     = {10.1038/s43587-024-00599-y},
  pmid    = {38514824},
  url     = {https://doi.org/10.1038/s43587-024-00599-y}
}

@article{hansson2023-37202517,
  author  = {Hansson, O. and Blennow, K. and Zetterberg, H. and Dage, J.},
  title   = {{Blood biomarkers for Alzheimer's disease in clinical practice and trials}},
  journal = {Nature aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00403-3},
  pmid    = {37202517},
  url     = {https://doi.org/10.1038/s43587-023-00403-3}
}

@article{cullen2021-37117993,
  author  = {Cullen, N. C. and Leuzy, A. and Palmqvist, S. and Janelidze, S. and Stomrud, E. and Pesini, P. and Sarasa, L. and Allué, J. A. and others},
  title   = {{Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations}},
  journal = {Nature aging},
  year    = {2021},
  doi     = {10.1038/s43587-020-00003-5},
  pmid    = {37117993},
  url     = {https://doi.org/10.1038/s43587-020-00003-5}
}